Nevirapine toxicity in non-HIV cancer patients

Chemotherapy

Volumn 54, Issue 6, 2008, Pages 475-478

  Landriscina, Matteo ^a   Fabiano, Annarita ^a   Lombardi, Valentina ^a   Santodirocco, Michele ^a   Piscazzi, Annamaria ^a   Fersini, Alberto ^a   De Vis, Koen ^c   Barone, Carlo ^b   Cignarelli, Mauro ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c St Elisabethziekenhuis ^*  (Belgium)

Author keywords

Differentiation; Human cancer; Immune response; Nevirapine; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; NEVIRAPINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 CD8 RATIO; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SAFETY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOLOGY; LIVER TOXICITY; LYMPHOCYTE COUNT; MELANOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PRURITUS; SIDE EFFECT; SKIN TOXICITY; THYROID CANCER;

AGED; HIV INFECTIONS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEVIRAPINE; THYROID NEOPLASMS;

EID: 52849110699     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159273     Document Type: Article

References (15)

1. Patel SM, Johnson S, Belknap SM, Chan J, Sha BE, Bennett C: Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 2004;35:120-125.
2. Taiwbo BO: Nevirapine toxicity. Int J STD AIDS 2006;17:364-369.
3. Landriscina M, Spadafora C, Cignarelli M, Barone C: Anti-tumor activity of non-nucleosidic reverse transcriptase inhibitors. Curr Pharm Des 2007;13:737-747.
4. Mangiacasale R, Pittoggi C, Sciamanna I, Careddu A, Mattei E, Lorenzini R, Travaglini L, Landriscina M, Barone C, Nervi C, Lavia P, Spadafora C: Exposure of normal and transformed cells to nevirapine, a reverse transcriptase inhibitors, reduces cell growth and promote differentiation. Oncogene 2003;22:2750-2761.
5. Landriscina M, Fabiano A, Altamura S, Bagalà C, Piscazzi A, Cassano A, Spadafora C, Giorgino F, Barone C, Cignarelli M: Reverse transcriptase inhibitors downregulate cell proliferation in vitro and in vivo and restore TSH signaling and iodine uptake in human thyroid anaplastic carcinoma. J Clin Endocrinol Metab 2005;90:5663-5671.
6. Landriscina M, Altamura SA, Roca L, Gigante G, Piscazzi A, Cavalcanti E, Costantino E, Barone C, Cignarelli M, Gesualdo L, Ranieri E: Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma. Int J Cancer 2008;122:2842-2850.
7. Sciamanna I, Landriscina M, Pittoggi C, Quirino M, Mearelli C, Beraldi R, Mattei E, Serafino A, Cassano A, Sinibaldi-Vallebona P, Garaci E, Barone C, Spadafora C: Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene 2005;24:3923-3931.
8. 131I uptake in a poorly-differentiated thyroid tumour in response to the reverse transcriptase inhibitor nevirapine. Lancet Oncol 2006;7:877-879.
9. Pontali E: Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals. Chemotherapy 2007;53:26-29.
10. Stern JO, Robinson PA, Love J, Lanes S, Imperiale MS, Mayers DL: A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients. J Acquir Immune Defic Syndr 2003;34(suppl 1):S21-S33.
11. Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH: Drug-induced liver injury: mechanisms and test systems. Hepatology 2001;33:1009-1013.
12. Jiang S, Lechler RI, He X, Huang J: Regulatory T cells and transplantation tolerance. Hum Immunol 2006;67:765-776.
13. Bossowski A, Urban M, Stasiak-Barmuta A: Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naïve (CD45RA) T cells in children with immune and non-immune thyroid diseases. J Pediatr Endocrinol Metab 2003;16:63-70.
14. Shenton JM, Popovic M, Chen J, Masson MJ, Uetrecht JP: Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. Chem Res Toxicol 2005;18:1799-1813.
15. Littera R, Carcassi C, Masala A, Piano P, Serra P, Ortu F, Corso N, Casula B, La Nasa G, Contu L, Manconi PE: HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients. AIDS 2006;20:1621-1626.